Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome

Journal of Nephrology

Volumn 22, Issue 5, 2009, Pages 610-615

  Ueda, Norishi ^a   Takahashi, Kazuhiro ^b   Akioka, Yuko ^b   Morooka, Masafumi ^c   Ogawa, Akimasa ^d   Tsuzuki, Kazuo ^e  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA CHILDREN'S HOSPITAL   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d ANJO KOSEI HOSPITAL   (Japan)

^e CHUKYO HOSPITAL   (Japan)

Author keywords

Chlorambucil; Cyclophosphamide; Minimal change nephrotic syndrome; Second course; Steroid dependence

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; PREDNISOLONE;

ARTICLE; CATARACT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DIABETES MELLITUS; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; GLAUCOMA; GROWTH DISORDER; HUMAN; HYPERTENSION; LEUKOPENIA; MALE; NEPHROTIC SYNDROME; ONSET AGE; OSTEOPOROSIS; PSYCHOSIS; RECURRENCE RISK; REMISSION; SEX RATIO; STEROID THERAPY;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CHILD, PRESCHOOL; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INFANT; MALE; NEPHROSIS, LIPOID; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME;

EID: 70649089449     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Latta K, von Schnakenburg C, Ehrich JH. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol. 2001;16:271-282.
2. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629-639.
3. Filler G. Treatment of nephrotic syndrome in children and controlled trials. Nephrol Dial Transplant. 2003;(Suppl 6):vi75-vi78.
4. Hodson EM, Craig JC, Willis NS. Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2005;20:1523-1530.
5. Barratt TM, Bercowsky A, Osofsky SG, Soothill JF, Kay R. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood. Lancet. 1975;1:55-58.
6. Williams SA, Makker SP, Ingelfinger JR, Grupe WE. Longterm evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med. 1980;302:929-933.
7. Kano K, Nishikura K, Hoshi M, Yamada Y, Arisaka O. Effectivenessof a second course of cyclophosphamide therapy in children with frequently relapsing nephrotic syndrome after cyclosporin A therapy. Clin Nephrol. 2001;55:424-425.
8. Bailey RR. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide. N Z Med J. 1989;102:379-381.
9. Srivastava RN, Mayekar G, Anand R, Choudhry VP, Ghai OP. Cyclophosphamide therapy in the management of nephrotic syndrome. Indian Pediatr. 1974;11:767-774.
10. Kashtan C, Melvin T, Kim Y. Long-term follow-up of patients with steroid-dependent, minimal change nephritic syndrome. Clin Nephrol. 1988;29:79-85.
11. Jones DP, Stapleton FB, Roy S III, Wyatt RJ. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephritic syndrome. Pediatr Nephrol. 1988;2:291-295.
12. Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome. Nephrol Dial Transplant. 2004;19:1136-1141.
13. Report of the International Study of Kidney Disease in Children. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Lancet. 1974;2:423-427.
14. Arbeitsgemeinschaft fur Padiatriche Nephrologie. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med. 1982;306:451-454.
15. Hiraoka M, Tsukahara H, Haruki S, et al. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. Kidney Int. 2000;58:1247-1252.
16. Vester U, Kranz B, Zimmermann S, Hoyer PF. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook. Pediatr Nephrol. 2003;18:661-664.
17. Kemper MJ, Altrogge H, Ludwig K, Timmermann K, Muller-Wiefel DE. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2000;14:772-775.
18. Qureshi MSA, Pennington JH, Goldsmith HJ, Cox PE. Cyclophosphamide therapy and sterility. Lancet. 1972;2:1290-1291.
19. Miller DG. Alkylating agents and human spermatogenesis. JAMA. 1971;217:1662-1665.
20. Watson AR, Rance CP, Bain J. Long term effects of cyclophosphamide on testicular function. Br Med J (Clin Res Ed). 1985;291:1457-1460.
21. Cheviakoff S, Calamera JC, Morgenfeld M, Mancini RE. Recovery of spermatogenesis in patients with lymphoma after treatment with chlorambucil. J Reprod Fertil. 1973;33:155-157.
22. Trompeter RS, Evans PR, Barratt TM. Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods. Lancet. 1981;1:1177-1179.